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Abstract

With the increasing incidence of drug addiction among pregnant women, neonatal abstinence
syndrome (NAS) has become a significant problem in the United States and has led to increased
hospital costs, longer lengths of stay, and more serious health problems in neonates. This
systematic review will explore the evidence about outcome differences for neonates with NAS
that receive breastfeeding, rooming-in, and acupuncture in addition to pharmacological agents
when compared to infants only receiving pharmacological agents. Twenty-one articles, retrieved
from the databases PubMed and CINAHL and published between the years 2000-2017, were
described in an integrated review, analyzed with critical appraisal, and synthesized for this
systematic review. In general, researchers have found that breastfeeding, rooming-in, and
acupuncture have positive effects of decreasing the need for pharmacological treatment, NAS
symptoms, hospital costs, and length of hospital stay for infants with NAS when used in
conjunction with pharmacologic agents.
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Systematic Review: The Effects of Pharmacological and Nonpharmacological Measures in
Neonates with Neonatal Abstinence Syndrome
The use or abuse of illicit drugs by mothers during pregnancy puts infants at risk for
neonatal abstinence syndrome. Illicit drugs cross the placentas and the fetuses can become
dependent on these substances. At birth, neonates are no longer exposed to these substances and
are then at risk for a wide range of withdrawal symptoms, known as neonatal abstinence
syndrome (NAS). NAS is a condition which primarily affects the autonomic and central nervous
systems, as well as the gastrointestinal system (Johnson, 2017). NAS causes many issues in
neonates and clinical manifestations of NAS can vary in both severity and timing (McQueen &
Murphy-Oikonen, 2016). Clinical manifestations of NAS typically develop within the first few
days of life and can range in severity from mild tremors and irritability to fever, excessive weight
loss, and seizures (McQueen & Murphy-Oikonen, 2016).
Neonatal abstinence syndrome is a significant problem in the United States (Corr &
Hollenbeak, 2017). Corr and Hollenbeak, (2017) revealed a 413% increase in the admissions of
neonates suffering from NAS from 2003 to 2012. Along with the large increase in admissions of
neonatal abstinence syndrome, the hospital lengths of stay also increased to the extent that
neonates with NAS had lengths of stay that were about three times higher than those neonates
not suffering from the syndrome. In 2003, NAS admissions cost the United States $60,643,042.
In 2012, this financial load reached an astounding value of $315,665,913 (Corr & Hollenbeak,
2017).
Neonatal abstinence syndrome not only affects health care costs, number of admissions,
and lengths of stay, but also has many detrimental effects on neonates (Corr & Hollenbeak,
2017). Approximately 225,000 neonates are exposed to illicit substances each year (MacMullen,
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Dulski, & Blobaum, 2014). Of the neonates exposed to drugs in utero, greater than 75% have
major medical problems, compared with 27% of unexposed infants (MacMullen et al., 2014).
Because infants suffering from NAS tend to have major medical problems, these infants require
extensive nursing care consisting of a number of interventions. Common interventions used to
treat infants suffering from NAS include pharmacological measures, such as methadone and
buprenorphine, and nonpharmacological measures, such as rooming-in, acupuncture, lowstimulation environment, and encouraging mothers to breastfeed neonates.
This systematic review was guided by the following PICOT question: In neonates with
neonatal abstinence syndrome, how do supplemental nonpharmacological measures, compared
with treatment as usual (pharmacological measure alone), affect outcomes? The purpose of this
systematic review is to describe and critically appraise the evidence about outcomes of
supplemental breastfeeding, rooming-in, and acupuncture in neonates with NAS, when compared
to neonates with NAS that received only pharmacological agents.
Methods
A systematic review of the literature was conducted to answer the PICOT question. The
databases PubMed and CINAHL were used to collect 21 peer reviewed journal articles published
between the year 2000 and 2017. Intervention types included pharmacological agents,
breastfeeding, and supportive interventions, including acupuncture, rooming-in, and reducing
stimulation in the environment. Key words were “breastfeeding,” “neonatal abstinence
syndrome,” “pregnancy and drug dependence and breastfeeding,” “neonatal abstinence
syndrome and medications,” “maternal methadone use and neonatal abstinence syndrome,”
“neonatal withdrawal syndrome and treatments,” “methadone maintenance program and neonatal
abstinence syndrome,” “neonatal abstinence syndrome and acupuncture,” “neonatal abstinence
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syndrome and interventions,” and “neonatal abstinence syndrome and rooming-in.” MeSH, or
Medical Subject Headings, is the National Library of Medicine’s controlled vocabulary thesaurus
that is used to index articles for Pubmed. MeSH included “neonatal abstinence syndrome,” “drug
therapy,” and “breastfeeding.” Integrated review, analysis with critical appraisal, and synthesis
of the reviewed articles were accomplished through the use of a matrix of evidence which
included the article’s title, author, purpose statement, research question, clinical practice setting,
sampling methods, sample size, research design, level of evidence, research findings,
practice/research implications, and limitations of findings (Appendix A).
Review of the Literature
Pharmacological interventions aimed at treating the symptoms of NAS have been studied
extensively. Opioid maintenance programs using methadone and buprenorphine are critical to
preventing NAS in order to improve the health of neonates (Kakko, Heilig, & Sarman, 2008). In
addition to pharmacological management of NAS, researchers have examined the effect of many
nonpharmacological methods on outcomes in neonates with NAS. For the purpose of this
systematic review, the interventions include breastfeeding, rooming-in, and acupuncture. This
systematic review of literature will provide an in-depth discussion of the studies that have
evaluated these interventions on NAS-related outcomes.
Pharmacological measures. In order to compare the treatments and outcomes for babies
with NAS, it is important to know the standard treatment provided today. Buprenorphine and
Methadone are the two most common pharmacological measures to reduce the severity of NAS
seen in babies born to opioid-dependant mothers (Kakko et al., 2008).
Target action. Opioid-dependent mothers are given Buprenorphine or Methadone early
in their pregnancy to reduce the effects of opioids on their unborn infants as part of an opioid
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maintenance program (Kakko et al., 2008). Opioid maintenance programs are very important to
the health of infants and the prevention of neonatal abstinence syndrome. Ebnar, Rohrmeister,
Winklbaur, Baewert, Jagsch, Peternell, and Fischer (2007) demonstrated that infants born to
mothers with drug addiction who were on an opioid maintenance program (N=53) showed
comparable APGAR scores with infants born to non-opioid dependent mothers (N=53). The
APGAR score is an assessment done at birth to determine if newborns are ready to live without
additional medical assistance. APGAR assessment focuses on five important factors of neonate
health: (1) baby’s appearance, (2) pulse, (3) muscle activity, (4) breathing and (5)
responsiveness.
Buprenorphine and Methadone are two drugs that are used to help persons addicted to
drugs avoid using illicit drugs. They target the same receptors that drugs, such as heroin, target,
therefore making persons with addiction feel satisfied, but in a more controlled and regulated
state to prevent the harmful side effect of withdrawal. Methadone is an opioid agonist, which
means that the drug binds to the central μ receptors and reduces pain impulses. It is used in
maintenance programs because it is easy to control and has a similar effect of illicit drugs but
does not give the euphoria, in turn decreasing reward responses and likelihood of addiction. This
drug is a schedule II, which means it is controlled and can potentially be very dangerous if
abused. On the other hand, Buprenorphine is a partial opioid agonist, which means that it is
weaker and there is less chance of abuse. An opioid antagonist, such as Narcan, is an antidote for
opioid agonists. Therefore, when Buprenorphine and Methadone are used in combination, the
persons feel as if they are on an opioid, but it is, in essence, a safe opioid used to prevent them
from abusing or overdosing. Buprenorphine is a schedule III, which means it has a lower risk of
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addiction than methadone, but still has potential to become dangerous (Kee, Hayes, &
McCuistion, 2009).
Research findings. Between Buprenorphine and Methadone, as used for opioid
maintenance, Buprenorphine has been found to be more effective (Jones, Kaltenbach, Heil,
Stine, Coyle, Arria, & Fischer, 2010; Kakko, et al., 2008). When mothers were given
Buprenorphine early in pregnancies, neonates are less likely to experience withdrawal, less
Morphine is required for treatment, higher birth weights and full term pregnancies result, and
hospital stays are shorter (Jones et al, 2010; Kakko et al, 2008). Ebnar et al. (2007) found that in
cases where mothers were not compliant with treatment or infants were experiencing withdrawal
symptoms, morphine, when given to the neonates, was the most effective treatment for neonatal
abstinence syndrome.
Several researchers have compared the effect of different opioid maintenance program
dosing schedules on NAS-related outcomes in neonates. Findings demonstrate no differences in
outcomes relative to program dosing schedules (Cleary, Reynolds, Eigan, O’connell, Fahey,
Gallagher, & Murphy, 2013; Kuschel, Austerberry, Cornwell, Couch, & Rowley, 2004).
Typically, some programs increase dosages of methadone in the later stages of pregnancy to
reduce the likelihood of mothers going into withdrawal or drug relapse, and others decrease
dosages in later stages to prevent neonates from going into neonatal abstinence syndrome. Cleary
et al. (2013) categorized dosing patterns into three categories: (1) increasing Methadone dosages
in later stages of pregnancies, (2) decreasing Methadone dosages in later stages of pregnancies,
or (3) no change in Methadone dosing throughout pregnancies. The outcome of medically treated
neonatal abstinence syndrome did not differ between groups (Cleary et al, 2013). However,
according to Kuschel et al. (2004), Methadone-exposed infants who required treatment for
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neonatal abstinence syndrome had lower amounts of methadone in their system than those who
did not receive treatment. The results of these studies suggest that dosages can remain consistent
throughout the opioid maintained pregnancies with little to no adverse effect on the neonate
(Cleary et al., 2013).
Summary. When women are addicted to illicit drugs, such as heroin, and they find they
are pregnant, they may be enrolled in opioid maintenance programs using either Buprenorphine
or Methadone. Both of these medications target the same receptors targeted by drugs such as
heroin, therefore decreasing the harmful side effect of withdrawal. When looking at these two
drugs, Buprenorphine has been found to be the superior. This drug regime resulted in less infants
going through withdrawal, less morphine required for treatment, higher birth weights due to
infants going full term, and shorter hospital stays (Jones et al, 2010; Kakko et al, 2008).
Although it is best to start on programs before conception, starting them as early as possible in
the pregnancy is shown to yield better outcomes. If neonates are born and show severe signs of
withdrawal, morphine has been shown to be the best drug for managing the symptoms (Ebnar et
al, 2007).
Breastfeeding. The effect of breastfeeding on NAS has been researched extensively in
the literature. Seven studies in this systematic review tested the effects of breastfeeding on NAS
(Dryden, Young, Hepburn, & Mactier, 2009; Isemann, Meinzen-Derr, & Akinbi, 2011;
McQueen, Murphy-Oikonen, Gerlach K, & Montelpare, 2011; Mohamed, Abde-Latif, Pinner,
Clews, Cooke, Lui, & Oei, 2006; O'Connor, Collett, Alto, & O'Brien, 2013; Pritham, Paul, &
Hayes, 2012; Welle-Strand, Skurtveit, Jansson, Bakstad, Bjarko, & Ravndal, 2013). These
researchers consistently showed that breastfeeding may reduce the incidence and duration of
pharmacological treatment of neonates with NAS, reduce the length of hospitalization, and
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reduce the severity of NAS. Description of studies in this integrated review are organized based
on those three outcomes. Samples of these seven studies included neonates suffering from NAS
ranging from 28 to 450 neonates; samples in five of the seven studies were greater than 120
neonates. Of the seven studies, the designs were retrospective cohort design, retrospective chart
review, and prospective design. Studies were conducted at hospitals, ranging from rural to innercity settings in the United States, Canada, United Kingdom, and Australia. Limitations of these
studies included small samples of buprenorphine-exposed infants, potential Finnegan
instrumentation bias, non-randomized group assignments due ethical considerations, and
retrospective data collection from available medical records, often resulting in incomplete data.
Incidence and duration of pharmacological treatment. As stated above, researchers
have consistently found that breastfeeding reduces incidence and duration of pharmacological
treatment in neonates exposed to methadone in utero (Dryden et al., 2009; Mohamed et al., 2006;
Welle-Strand et al., 2013). Breastfeeding for greater than 72 hours was associated independently
with a 50% reduced need for pharmacological treatment of NAS in methadone-exposed infants
(Dryden et al., 2009). According to Welle-Strand et al. (2013), only 53% of the methadoneexposed infants being breastfed required pharmacological treatment while 80% of the
methadone-exposed infants not being breastfed required pharmacological treatment for NAS.
Similarly, Mohamed et al. (2006), found that 52.9% of the breastfed infants required
pharmacological treatment for withdrawal while 79.0% of the formula-fed infants required
pharmacological treatment for withdrawal.
Breastfeeding has also been found to shorten length of pharmacological treatment of
NAS in infants exposed to methadone (Isemann et al., 2011; Mohamed et al., 2006; Welle-Strand
et al., 2013). According to Welle-Strand et al. (2013), a significantly shorter duration of
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pharmacological treatment of NAS was found in methadone-exposed infants linked to lactation
status. The duration of treatment for breastfed infants exposed to methadone was 31 days while
the duration of treatment for methadone-exposed infants who were not breastfed was 48.9 days.
Likewise, Isemann etal. (2011) discovered that maternal breast milk feedings decreased median
duration of methadone therapy for NAS in both preterm and term infants. The median duration
of methadone therapy for NAS in breastfed infants was less than ten days while the median
duration of methadone therapy in formula-fed infants was greater than ten days. Lastly,
Mohamed et al. (2006) found that overall NAS pharmacological treatment duration was almost
20 days less in breastfed infants compared to formula-fed infants. The duration of
pharmacological treatment for breastfed infants was 85.4 days while the duration of treatment for
formula-fed infants was 108.2 days.
Hospital stays. Additionally, researchers have found that infants suffering from NAS
who were breastfed had shorter hospital stays than formula-fed infants suffering from NAS
(Isemann et al., 2011; Mohamed et al., 2006; Pritham et al., 2012). According to Isemann,
Meinzen-Derr, and Akinbi (2011), maternal breast milk decreased hospital length of stay
compared to formula-fed infants. The median length of hospital stay for breastfed infants
suffering from NAS was 12.5 days while the median length of stay for formula-fed infants was
18.5 days. Mohamed, Abde-Latif, Pinner, Clews, Cooke, Lui, and Oei (2006) found similar
results with a shorter length of hospitalization among breastfed infants compared to formula-fed
infants. In their study, the length of hospitalization in breastfed infants was 14.7 days compared
to 19.1 days in formula-fed infants.
Severity of NAS. Breastfeeding has also been found to reduce severity of NAS (Isemann
et al., 2011; McQueen et al., 2011; Mohamed et al., 2006; O’Connor et al., 2013). The incidence

NEONATAL ABSTINENCE SYNDROME

11

and severity of NAS is measured using the Finnegan objective scoring system. Finnegan scoring
systems assess the severity of NAS by observing central nervous system, gastrointestinal,
respiratory, and vague autonomic symptoms in infants. Finnegan scores determine whether or
not pharmacological treatment for NAS will be initiated and also help to determine the dosing
regimen of the chosen pharmacological method. It should be noted that the Finnegan scoring
system is only validated for opiate withdrawal; therefore, it may not be an accurate scoring
system for neonates exposed to other substances (Mohamed et al., 2006).
Isemann, Meinzen-Derr, and Akinbi (2011) used the Finnegan abstinence scoring method
to measure the severity of NAS. Their findings suggested that the volume of maternal breast milk
ingested reduced incidence and severity of NAS in both preterm and term infants. Similarly,
Mohamed, Abde-Latif, Pinner, Clews, Cooke, Lui, and Oei (2006) monitored infants for NAS
using the Finnegan objective scoring system and found that breastfed infants exposed to multiple
drugs in utero had worse Finnegan scores than infants exposed to only a single drug in utero, but
had significantly better scores than formula-fed infants.
McQueen, Murphy-Oikonen, Gerlach, and Montelpare (2011) used a modified Finnegan
Scoring Tool that consisted of 30 items used to measure withdrawal including central nervous
system, metabolic, vasomotor, respiratory, and gastrointestinal symptoms. In this modified
Finnegan Scoring Tool, the maximum score that could be recorded was 44 while the minimum
score was 0. A score of eight or greater suggested withdrawal in neonates (McQueen et al.,
2011). Initial scores were recorded at birth and every two hours after birth for the first 48 hours
for the neonate exposed to methadone in utero. Afterwards, scores were recorded every 4 hours
for 72 hours and then as required by hospital policy. If scores greater than 8 were recorded,
further scores were recorded every two hours. The number of NAS scores recorded differed
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between breastfed and formula-fed infants. The mean number of NAS scores recorded of
predominantly breastfed infants was 25.0 while the mean number of scores recorded for formulafed infants was 95.6 (McQueen et al., 2011). Additionally, the predominantly breastfed infants
had a lower severity of NAS symptoms than the formula-fed infants indicated by a lower
magnitude Finnegan score. The overall mean NAS score of breastfed infants was 4.9 while the
mean overall NAS score of formula-fed infants was 6.9 (McQueen et al., 2011). A limitation to
this study is that the reliability and validity of this tool was not established; therefore, some
instrumentation bias may have existed (McQueen et al., 2011).
O’Connor, Collett, Alto, and O’Brien (2013) also used a modified Finnegan Scoring
System to measure the degree of withdrawal symptoms in buprenorphine-exposed neonates. The
results suggest that breastfeeding may reduce the severity of NAS in infants exposed to
buprenorphine. The mean peak NAS score of breastfed infants was 8.83 while the mean peak
NAS score of non-breastfed infants was 9.65. If three or more consecutive scores greater than or
equal to 8 were recorded for infants, pharmacological treatment of NAS was indicated. Breastfed
infants were less likely to score greater than or equal to 8 than non-breastfed infants.
Additionally, symptoms of NAS were found to resolve about two hours earlier in breastfed
infants than in formula-fed infants. A limitation to this study was the ability to control all
variables. Some nonpharmacological interventions for NAS occur with breastfeeding, so it is not
possible to distinguish the potential impact of breastfeeding from interventions such as
swaddling or kangaroo care on the reduction of NAS symptoms (O’Connor et al., 2013).
Multiple studies have found reduced need for pharmacological treatment for NAS in
breastfed infants exposed to buprenorphine (O’Connor et al., 2013; Pritham et al., 2012).
According to O’Connor et al. (2013), buprenorphine-exposed neonates who were breastfed were
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less likely to require pharmacological management of NAS than buprenorphine-exposed infants
who were not breastfed. They discovered that 23.1% of breastfed infants of mothers maintained
on buprenorphine during pregnancy required treatment for NAS while 30.0% of non-breastfed
infants required treatment for NAS.
While some researchers have found decreased incidence of pharmacological treatment for
NAS in breastfed infants exposed to buprenorphine, Welle-Strand, Skurtveit, Jansson, Bakstad,
Bjarko, and Ravndal (2013) found no reduced need for pharmacological management of NAS in
buprenorphine-exposed infants when breastfeeding was introduced. In their study, 64% of
breastfed infants exposed to buprenorphine required pharmacological treatment for NAS while
44% of buprenorphine-exposed infants who were not breastfed required treatment for NAS. The
cohort in their study consisted of both women in methadone maintenance treatment and women
in buprenorphine maintenance treatment which allowed for the comparison of the effects of both
drugs on the neonate; however, the study groups, especially for buprenorphine, were small. The
study group consisted of 78 infants exposed to methadone and 46 infants exposed to
buprenorphine. The small study groups made it difficult to detect any significant differences
between buprenorphine-exposed infants who were breastfed and buprenorphine-exposed infants
who were not breastfeed (Welle-Strand et al., 2013). Future research needs to examine if
breastfeeding reduces the need for pharmacological treatment for NAS in infants exposed to
buprenorphine (O’Connor et al., 2013; Welle-Strand et al., 2013).
Summary. Researchers studying the effects of breastfeeding consistently found that
breastfeeding may reduce the incidence and duration of pharmacological treatment of NAS,
reduce the length of hospitalization, and reduce the severity of NAS(Dryden et al., 2009;
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Isemann et al., 2011; McQueen et al., 2011; Mohamed et al., 2006; O'Connor et al., 2013;
Pritham et al., 2012; Welle-Strand et al., 2013).
Rooming-In. Non-pharmacological measures such as rooming-in are commonly used
along with pharmacological measures to treat neonatal abstinence syndrome. Four studies in this
systematic review tested the effects of rooming-in on neonatal abstinence syndrome (Abrahams,
Kelly, Payne, Thiessen, Mackintosh, & Janssen, 2007; Grossman, Berkwitt, Osborn, Xu,
Esserman, Shapiro, & Bizzaro, 2017; Holmes, Atwood, Whalen, Beliveau, Jarvis, Matulis, &
Ralston, 2016; Newman, Davies, Dow, Holmes, Macdonald, Mcknight, & Newton, 2015). The
researchers measured outcomes of length of hospital stay, hospital cost, severity of NAS
symptoms, and need for pharmacological treatment. Samples included neonates suffering from
NAS with sample sizes ranging from 26 to 287 neonates. Three of the four studies included had
sample sizes under 45 neonates. Of the four studies, the designs were retrospective cohort design
and retrospective chart review. Each study took place in single-site hospitals, ranging from rural
to inner-city settings. The studies took place in British Columbia, United States, and Ontario.
Limitations of these studies included small samples, potential biases in NAS scoring systems due
to the scoring tool relying on some subjective data, inconsistencies in pharmacological treatment,
changes in hospital policies during the course of the study, and non-randomized group
assignment.
Across studies researchers consistently found that admitting neonates directly to inpatient
rooms, by-passing neonatal intensive care units (NICU), led to shorter lengths of hospital stay,
decreased hospital costs, reduced severity of NAS symptoms, and decreased need for
pharmacological treatment (Abraham et al., 2007; Grossman et al., 2017; Holmes et al., 2016;
Newman et al., 2015). For example, Grossman et al. (2017) studied 287 neonates with NAS at
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Yale New Haven Children’s Hospital and investigated the effects of implementing
nonpharmacological interventions, administering morphine, and transferring infants directly to
the inpatient unit on the average length of hospital stay for infants with NAS. This was a longterm study in which the researchers collected data from January 2008 until June 2016. In March
2010 a quality improvement (QI) project was implemented at this hospital. The QI project had
neonates placed in a low stimulation environment, and encouraged parents to room-in,
continuously care for their neonates, feed their neonates on demand, and tend to neonates if
crying. Mothers were encouraged to breastfeed infants as long as there were no
contraindications, such as HIV. Staff was trained to view nonpharmacological interventions as
equal to pharmacological interventions, and to increase parent involvement before implementing
pharmacological treatment. The use of the Finnegan Neonatal Abstinence Scoring system
(FNASS) was discontinued and instead a functional assessment was developed that focused on
the infant’s ability to eat, sleep, and be consoled. The scores of this functional assessment
determined whether or not the infant needed to be given morphine. Of the 421 infants over the
gestational age of 35 weeks that were diagnosed with NAS during the study period, only 287
were included in the study. Those excluded were infants either not exposed to methadone or
those with serious comorbid conditions. Of the 287 infants, 55 were in the pre-implementation
period, 188 in the intervention period, and 44 in the post-implementation period. The preimplementation and post-implementation periods had to do with the QI project that was
implemented in March 2010. Infants born before March 2010 were part of the preimplementation period, and infants born after May 2015 were considered part of the postimplementation period. The average length of stay (ALOS) decreased from 22.4 days in the pre-
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implementation to 5.9 days in the post-implementation period; and the proportion of infants
treated with morphine decreased from 98% to 14%.
Grossman et al. (2017)’s findings about decreased length of hospital stay are in line with
those of Abrahams et al. (2007), who examined the effects of rooming-in on need for
pharmacological treatment, need for admission to a neonatal intensive care nursery, and ALOS,
all of which represented severity of NAS symptoms. Specifically, Abrahams et al (2007)
conducted the study at a hospital in Vancouver, British Columbia and compared outcomes of
three subsamples of mothers who used heroin or methadone during pregnancy (Abrahams et al.,
2007). The study cohort consisting of 32 new mothers admitted to BC Women’s Hospital
(BCWH) between October 2001 and December 2002, was compared to two historical cohorts
that consisted of women who gave birth between January 1999 and September 2001. The study
cohort took place after the implementation of rooming-in at BCWH. Mothers were instructed by
nurses about how to care for infants and how to identify symptoms of NAS. The first historical
cohort consisted of 38 women who disclosed use of heroin or methadone during pregnancy. The
second historical cohort consisted of 36 women who also reported use of heroin or methadone.
The women in the historical cohorts received the same care as those in the study cohort, but had
not had rooming-in; instead, infants were admitted to a level II nursery. Outcomes of this study
demonstrate that rooming-in was associated with a decreased need for pharmacological
treatment, decreased need for admission to a neonatal intensive care nursery, and decreased
ALOS. A limitation of this study was that the effects of rooming-in could not be separated from
the effects of breastfeeding. Sixty percent of women in the study cohort breastfed, while only
10% of women in the comparison groups breastfed.
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Summary. Researchers consistently found that rooming-in led to shorter length of
hospital stay, decreased hospital costs, reduced severity of NAS symptoms, and decreased need
for pharmacological treatment, suggesting reliability of this group of studies.
Acupuncture. Another non-pharmacological intervention used for infants suffering from
NAS is acupuncture. Two studies tested the effects of acupuncture on the treatment of NAS
(Filippeli, White, Spellman, Broderick, Highfield, Sommers, & Gardiner, 2012; Raith,
Schmolzer, Resch, Reiterer, Avian, Koestenberger, & Urlesberger, 2015). Raith et al. (2015)
examined the effect of laser acupuncture on length of morphine treatment and average length of
hospital stay in 28 neonates at a hospital in Austria. Laser acupuncture increases the levels of
endomorphin, endorphins, encephalin, and serotonin and causes analgesia and sedation. The
design of the study was a randomized, controlled, blinded, single-center study. The study was
blinded by having both the control group and the test group spend time in the treatment room
where the test group received acupuncture treatment and the control group simply spent time
lying in bed. The use of laser acupuncture was found to significantly decrease the duration of
morphine therapy in newborns with NAS. The median drug treatment for the acupuncture group
was 28 days compared to 39 days for the control group. Neonates who received laser
acupuncture also had shorter lengths of hospital stay. The ALOS for the acupuncture group was
35 days compared to 50 days for the control group. While this study suggests that laser
acupuncture is a safe way to reduce length of morphine treatment and ALOS, the small sample
must be taken into consideration as a limitation to this study.
Filippeli et al. (2012) looked at the effects of non-insertive acupuncture (NIA) on the
symptoms associated with NAS in a retrospective chart review of 54 neonates with NAS The
neonates received a total of 92 NIA sessions, which involved an acupuncturist stimulating seven
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acupuncture points with a teishin or finger. The researchers found that 28 neonates slept through
the treatment or fell asleep immediately after the treatment. Of those who slept through the
treatment, one neonate experienced deeper sleep following treatment. Effects were more
prominent in neonates who were agitated prior to treatment. Additionally, 13 neonates exhibited
signs of released tension during NIA treatment. Findings also revealed that better feeding
followed NIA treatment, with eight neonates showing higher caloric intake for the days
following treatment. The infants receiving NIA as an adjunctive treatment along with
pharmacological interventions were found to reveal deeper sleep, better feedings, and more even
breathing. A limitation of this study was that acupuncturists were only available one day a week
resulting in some infants being treated early in their stay and others being treated later in their
stay.
Critical Appraisal
In general, researchers have found that breastfeeding, rooming-in, and acupuncture have
positive effects of decreasing the need for pharmacological treatment, NAS symptoms, hospital
costs, and length of hospital stay for infants with NAS when used in conjunction with
pharmacologic agents. In this section, quality (validity and reliability) of the studies is discussed
with pharmacology studies discussed first, followed by studies about breastfeeding, rooming, and
then acupuncture.
Pharmacological methods. There is an abundant amount of research about
pharmacological interventions of babies with NAS. The six studies that were included in this
systematic review were appraised on validity and reliability (Cleary et al., 2013; Dryden et al.,
2009; Ebnar et al., 2007; Jones et al., 2010; Kakko, et al., 2008; Kuschel et al., 2004). Because
the findings across studies were consistent, it can be concluded that they are reliable. Validity
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was questioned with the studies relating to small samples (Cleary et al., 2013; Ebnar et al., 2007;
Kakko, et al., 2008; Kuschel et al., 2004), no group randomization (Ebnar et al., 2007; Kakko et
al., 2008; Kuschel et al., 2004), dosages not being stated (Jones et al., 2010), attrition, e.g.,
participants not showing to follow up appointments (Dryden et al., 2009), and varying severities
of addiction and age of the pregnant women (Kakko et al., 2008).
Designs of these studies show many strengths and include: prospective cohort (Cleary et
al., 2013; Kakko et al., 2008), retrospective (Dryden et al., 2009), double-blind, double-dummy
(Jones et al., 2010) random and controlled (Jones et al., 2010). The level of evidence on these
studies is also something to consider when discussing validity and limitations. Levels of
evidence were: level III (Dryden et al., 2009), level V (Jones et al., 2010), level VI (Ebnar et al.,
2007; Kakko et al., 2008; Kuschel et al., 2004), and level VII (Cleary et al., 2013). Internal
validity was also increased when participants were all on the same medication, because it was
easier to conclude findings of the particular medication. In three of the studies, researchers
looked at women who were only on Methadone, which allowed researchers to compare data
pertaining to this specific drug along with other variables that may be present (Cleary et al.,
2013; Dryden et al., 2009; Kuschel et al., 2004).
Breastfeeding. Breastfeeding and its effects on NAS has been researched extensively in
the literature. Researchers of seven studies in this systematic review tested the effects of
breastfeeding on abstinence syndrome (Dryden et al., 2009; Isemann et al., 2011; McQueen et
al., 2011; Mohamed et al., 2006; O'Connor et al., 2013; Pritham et al., 2012; Welle-Strand et al.,
2013). The consistent findings across studies suggest the reliability of studies. As previously
noted, limitations of study and threats to internal and external validity included small samples of
buprenorphine-exposed neonates (Welle-Strand et al., 2013), affecting the statistical conclusion
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validity of findings; however, breastfeeding in larger samples of methadone-exposed infants
were studied in the literature. Researchers found that breastfeeding had positive outcomes
whether using smaller samples of buprenorphine-exposed or larger samples of methadoneexposed infants (Dryden et al., 2009; Isemann et al., 2011; Mohamed et al., 2006; Pritham et al.,
2012; Welle-Strand et al., 2013).
Potential Finnegan instrumentation bias was also noted and contributes to threats to
internal validity (Isemann et al., 2011). A modified Finnegan scoring tool was used by
researchers in two studies (O’Connor et al., 2013; McQueen et al., 2011). The reliability and
validity of the modified Finnegan scoring tool is not well-established but it has been used in
numerous studies to guide and compare various treatments for NAS (McQueen et al., 2011). The
Finnegan abstinence scoring method is a subjective assessment of NAS designed for term infants
and may not be sensitive to detecting NAS in preterm infants. However, more term neonates
were included in the research than preterm neonates (Isemann et al., 2013). Additionally, while
the Finnegan scoring system is only validated for opiate withdrawal, no reliable system has been
created to assess non-opiate effects. However, the majority of the participants in the samples
were exposed to opiates (Mohamed et al., 2006).
Researchers also used retrospective data collection from available medical records, which
may have resulted in missing data (Dryden et al., 2009; Isemann et al., 2011; McQueen et al.,
2011; Mohamed et al., 2006; O’Connor et al., 2013; Pritham et al., 2012; Welle-Strand et al.,
2013). However, retrospective data collection is an efficient way to collect data from larger
samples and it minimizes recall bias. Retrospective data collection is valuable and is often used
to direct future retrospective data collection in research. While the majority of the researchers
used retrospective data collection from available medical records, researchers of one cohort
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study used a prospective data collection. The researchers compared background characteristics,
pregnancy variables, and neonatal outcomes linked to feeding method across the three study
groups (Welle-Strand et al., 2013).
Rooming-in. Researchers of four studies researched the effects of rooming-in on
outcomes in neonates with NAS (Abrahams et al., 2007; Grossman et al., 2017; Holmes et al.,
2016; Newman et al., 2015), measuring outcomes of average length of hospital stay, average
hospital cost, severity of NAS symptoms, and need for pharmacological treatment. Sample sizes
across studies ranged from 26 to 287 infants, with samples in three of the four studies of less
than 45 infants. Researchers consistently found that rooming-in led to shorter length of hospital
stay, decreased hospital costs, reduced severity of NAS symptoms, and decreased need for
pharmacological treatment, suggesting reliability of this group of studies. Because findings of
these studies are consistent despite having different settings and populations, these practices can
likely be applied to other populations and have similar outcomes. Limitations of these studies
included small samples (Abraham et al., 2007; Newman et al., 2017), potential biases in NAS
scoring systems due to the scoring tool relying on some subjective data (Newman et al., 2015),
inconsistencies in pharmacological treatment (Holmes et al., 2016), changes in hospital policies
during the course of the study (Grossman et al., 2017), and non-randomized allocation of
subjects to study groups (Abrahams et al., 2007).
Acupuncture. Another non-pharmacological intervention used for neonates with NAS is
acupuncture. Researchers of two studies examined the effects of acupuncture on outcomes in
neonates with NAS (Filippeli et al., 2012; Raith et al., 2015). One group of researchers examined
the effect of laser acupuncture in 28 newborns to test two outcomes: length of morphine
treatment and average length of hospital stay (Raith et al., 2015). The use of laser acupuncture
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was found to increase endorphins and lead to analgesia, which significantly decreased duration
of morphine therapy and length of hospital stay in newborns with NAS. While these researchers
found that the use of laser acupuncture has favorable outcomes, the small sample must be taken
into consideration as a limitation to this study and threat to external validity.
In another study regarding acupuncture, researchers also looked at the effects of noninsertive acupuncture (NIA) on the symptoms associated with NAS (Filippeli et al., 2012). In the
study, 54 infants received a total of 92 NIA sessions, which involved an acupuncturist
stimulating seven acupuncture points with a teishin or finger. The infants receiving NIA as an
adjunctive treatment along with pharmacological interventions were found to have deeper sleep,
better feedings, and more even breathing. A limitation of this study was that acupuncturists were
only available one day a week, resulting in some infants being treated early in their stay and
others being treated later in their stay. While the findings in this study demonstrated reliability
and internal validity, this single study is not enough to conclude external validity.
Synthesis
Breastfeeding. Researchers have found that breastfeeding as a nonpharmacological
measure reduced the incidence and length of pharmacological management of NAS, reduced the
length of hospital stay, and reduced the incidence and severity of NAS symptoms (Dryden et al.,
2009; Isemann et al., 2011; McQueen et al., 2011; Mohamed et al., 2006; O'Connor et al., 2013;
Pritham et al., 2012; Welle-Strand et al., 2013). Strengths of studies included large samples of
methadone-exposed neonates with NAS and the reduction of recall bias through the use of
retrospective data collection. Instruments used to measure the severity of NAS were consistent
across studies. Based on the critical appraisal of these studies, breastfeeding as a
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nonpharmacological method should be used in addition to pharmacological methods to reduce
the incidence, length, and severity of NAS as well as reduce the length of hospital stay for NAS.
Rooming-in. Researchers found that the use of nonpharmacological method of roomingin has reduced average length of stay, reduced hospital costs, reduced severity of NAS
symptoms, and decreased the need for pharmacological treatments (Abrahams et al., 2007;
Grossman et al., 2017; Holmes et al., 2016; Newman et al., 2015). Based on the critical appraisal
of these studies, findings were consistent across studies, therefore suggesting reliability.
Researchers of these studies did see a change in anticipated outcomes, therefore confirming that
rooming-in leads to favorable outcomes.
Acupuncture. Researchers have found that the use of different acupuncture techniques as
an adjunctive therapy reduced length of stay, decreased need for pharmacological treatment,
decreased signs of discomfort in neonates, and increased feeding times (Filippeli et al., 2012;
Raith et al., 2015). The purpose of acupuncture is to achieve pain relief. These studies supported
this theory by examining for signs of increased comfort following acupuncture therapy, and
examining the effect acupuncture has on length of stay, and need for pharmacological treatment.
Although these preliminary findings are promising and consistent for effects on positive
outcomes, external validity cannot be implied from these two studies alone.
Implications and Recommendations for Practice
Pharmacological methods. Based on the evidence, it is important for nurses to motivate
and enroll new mothers in opioid maintenance programs for the health and safety of their babies
(Ebnar et al., 2007). It is important to start them as early as they can, even before pregnancy if
possible (Kakko et al., 2008). If a mother is noncompliant and the neonate goes into withdrawal,
it is important for nurses to use morphine to manage symptoms (Ebnar et al., 2007). Future
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researchers should conduct studies with larger samples, control groups, and control statistically
for extraneous variables, since randomized group assignment is rarely used in research about this
topic. There should also be research about compliance to opioid maintenance programs and
effectiveness of interventions, e.g., motivational interviewing, on outcomes to increase
compliance rates.
Breastfeeding. Based on quality of evidence of this systematic review, pregnant women
who misuse drugs should be strongly encouraged and supported to breastfeed in the absence of
any contraindications (Dryden et al., 2013; Isemann et al., 2011; McQueen et al., 2011;
Mohamed et al., 2006; Pritham et al., 2012; Welle-Strand et al., 2013). Breastfeeding education
should be provided to these women during the prenatal period, early in their pregnancies
(O’Connor et al., 2013; McQueen et al., 2011; Welle-Strand et al., 2013). Information about
breastfeeding from interdisciplinary healthcare professions should be consistent (Welle-Strand et
al., 2013). An extended postnatal stay may also be beneficial so nurses can watch for signs of
NAS and it would also allow healthcare professionals to continue to support breastfeeding and
provide parenting support (Dryden et al., 2013). Future research needs to be conducted to
continue to examine effects of breastfeeding on outcomes in neonates with NAS, especially in
those exposed to buprenorphine (Welle-Strand et al., 2013). Additional research should be
conducted to explore issues such as reasons for low breastfeeding rates among drug-misusing
women and effective interventions to support these women to breastfeed (McQueen et al., 2011).
Rooming-in. Based on the evidence, rooming-in contributes to favorable outcomes for
neonates with NAS and therefore should be implemented in hospital settings (Abrahams et al.,
2007; Grossman et al., 2017; Holmes et al., 2016; Newman et al., 2015). Further research would
be beneficial to provide more evidence. Future studies should consider using randomized groups
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and larger samples. Researchers should also ensure consistencies in pharmacological treatment
and the use of breastfeeding in participants. Further, researchers should look into the effects
rooming-in has on medium and long-term childhood outcomes, such as growth, development,
and behavioral outcomes of participants (Grossman et al., 2017; Newman et al., 2015). Future
studies could also examine quality of mother-infant bonding and other longer term outcomes,
such as involvement of child protective services (Newman et al.,2015).
Acupuncture. Based on evidence, the use of laser acupuncture reduced length of
pharmacological treatment and reduced length of hospital stay (Raith et al., 2015). Evidence has
also shown that non-insertive acupuncture increased comfort, deeper sleep, and better feedings in
neonates with NAS (Filippeli et al., 2012). Findings suggest that both laser acupuncture and NIA
could be used as an adjunct to other standard treatment. Acupuncture could be especially useful
in hospitals in areas with high prevalence of drug use, in which there is higher occurrences of
neonates with NAS (Filipelli et al., 2012). While research has shown favorable outcomes from
both laser acupuncture and NIA, more research should be conducted to ensure safety and
efficacy of acupuncture in neonates. Further research should include larger randomized
controlled studies. Future studies should consider investigating mother-delivered NIA and its
effects on mother-neonate bonding (Filippeli et al., 2012) and also the possibility of at home
laser acupuncture treatment programs (Raith et al., 2015).
Conclusion
The management of neonates with NAS has evolved and improved greatly over the past
twenty years. These advances have been supported by evidence about the effects of
nonpharmacological interventions on outcomes of neonates with NAS. Breastfeeding may
reduce the incidence and duration of pharmacological treatment of neonates with NAS, reduce
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the length of hospitalization, and reduce the severity of NAS (Dryden et al., 2009; Isemann et al.,
2011; McQueen et al., 2011; Mohamed, Abde-Latif et al., 2006; O'Connor et al., 2013; Pritham
et al., 2012; Welle-Strand et al., 2013). When combined with Buprenorphine, the best choice for
a pharmacological treatment, outcomes in this population have significantly improved. Infants
with NAS receiving nonpharmacological interventions, such as rooming-in and acupuncture, are
found to have better outcomes than infants receiving only pharmacological treatment (Abrahams
et al., 2007; Filippeli et al., 2012; Grossman et al., 2017; Holmes et al., 2016; Newman et al.,
2015; Raith et al., 2015). Overall, researchers have found that breastfeeding, rooming-in, and
acupuncture have positive effects of decreasing the need for pharmacological treatment, NAS
symptoms, hospital costs, and length of hospital stay for infants with NAS when used in
conjunction with pharmacologic agents.
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Appendix A
APA formatted
reference

Purpose
statement,
Research
question.

Abrahams, R.,
Kelly, S., Payne,
S., Thiessen, P.,
Mackintosh, J.,
& Janssen, P.
(2007).
Rooming-in
compared with
standard care for
newborns of
mothers using
methadone or
heroin.
Canadian
Family
Physician,
53(10), 17221730.

Purpose
Statement:
To evaluate the
effect of
rooming-in
rather than
standard nursery
care on the
severity of NAS.

Cleary, B. J.,
Reynolds, K.,
Eogan, M.,
O'connell, M. P.,
Fahey, T.,
Gallagher, P. J.,
& ... Murphy, D.
J. (2013).
Methadone
dosing and
prescribed
medication use
in a prospective
cohort of opioiddependent
pregnant women.

Purpose
statement: To
describe
methadone
dosing during
and after
pregnancy, to
compare
occurrences of
NAS between
those with dose
decreases and
those with steady
or increasing
doses, and to
describe

Clinical
Practice
Setting,
Sampling
methods,
Sample size
Setting:
British
Columbia

Design.
Level of
Evidence

Findings,
Conclusion

Practice &
Research
Implications

Limitations
of Findings

Design:
retrospective
cohort study
Level of
Evidence:
level III

Rooming-in
might ease
newborns’
transition to
extrauterine life
and promote
more effective
mothering.

Non-random
allocation of
subjects to
study groups

Sampling
Method:
convenience

Rooming-in
was associated
with a
significant
decrease in
need for
treatment of
NAS compared
with the
control.
Rooming-in
was also
associated with
shorter
newborn LOS
and newborns
were more
likely to be
discharged in
the custody of
their mothers.
Incidence of
treatment of
NAS did not
differ between
dosage groups.

There is no
need to
decrease the
methadone
dosing during
pregnancy
because the
dosing has no
effect on the
outcome of the
neonate with
NAS.

Maternal
noncomplian
ce, sample
size
limitations.

Sample Size:
32 women
Research
who used
Question:
heroin or
Does rooming-in methadone
reduce the
during
severity of NAS? pregnancy

Setting: Two
Irish tertiary
care
maternity
hospitals
Sampling
Method: not
stated
Sample Size:
117 pregnant
women on
methadone
maintenance
treatment

Design:
prospective
cohort study
Level of
Evidence:
level VII
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prescribed
between July
medication use
2009 to July
among opioid2010
dependent
pregnant women.

Research
Question: What
dose of
methadone is
most effective
for neonates
suffering from
NAS?
Corr, T. E., &
Purpose
Hollenbeak, C.
Statement: To
S. (2017). The
describe the
economic burden NAS population
of neonatal
and compare
abstinence
with the
syndrome in the non-NAS
United States.
population,
Addiction,
determine the
112(9), 1590incidence of
1599.
NAS in the
doi:10.1111/add. United States
13842
and estimate the
total annual costs
and hospital
days of NAS
admissions, and
estimate the
incremental costs
and length of
stay of an NAS
admission
compared with a
nonNAS admission.
Research
Question: What
effect does NAS
have on the
united states

Setting:
United States
hospitals
from states
that used KID
(Kids’
Inpatient
Database) - a
program that
nationally
represents a
sample of
pediatric
discharges.
Sampling
Method:
randomly
from the KID
Sample Size:
patients
diagnosed
with NAS
(27,943)
compared to
non-NAS
patients
(3,783,629)

Design:
retrospective,
observational
study
Level of
Evidence:
level III

From 2003 to
2012, NAS
admissions
increased by
nearly 4 times,
causing a major
increase in
costs for the
United States
(around $61 to
316 million).
Hospital stays
were three
times longer.

Research
implications: to
reduce
healthcare
costs, NAS
needs to be
treated better.
The use of
opioid
maintenance
programs
should be
implemented
and people
should be
educated on the
effects of
opioids and
other illicit
drugs.

No
limitations
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economic
system?
Dryden, C.,
Young, D.,
Hepburn, M., &
Mactier, H.
(2009). Maternal
methadone use
in pregnancy:
factors
associated with
the development
of neonatal
abstinence
syndrome and
implications for
healthcare
resources.
BJOG: An
International
Journal Of
Obstetrics &
Gynaecology,
116(5), 665-671.
doi:10.1111/j.14
710528.2008.0207
3.x

Purpose
Statement: To
investigate
factors
associated with
the development
of neonatal
abstinence
syndrome (NAS)
and to assess the
implications for
health care
resources of
infants born to
drug-misusing
women.

Setting:
Neonatal
Unit, Princess
Royal
Maternity,
Glosgow, UK
(Inner-city
maternity
hospital
providing
dedicated
multidisciplin
ary care to
drugmisusing
women)

Research
Questions: What
factors are
associated with
NAS? What are
the implications
for health care
resources of
infants born to
drug-misusing
mothers?

Sampling
Method: the
charts of all
singleton
infants born
to drugmisusing
women
prescribed
substitute
methadone
and delivered
at Princess
Royal
Maternity in
Glasgow over
the 3-year
period from 1
January 2004
to 31
December
2006 were
reviewed
Sample Size:
450 singleton

Design:
retrospective
cohort study
from 1
January 2004
to 31
December
2006
Level of
Evidence:
level III

Breastfeeding
was associated
with reduced
odds of
requiring
treatment for
NAS.
Breastfeeding
for greater than
72 hours was
independently
associated with
a halving of the
odds of the
infant receiving
pharmacologic
treatment of
NAS.

Practice
Implications:
pregnant drugmisusing
women should
be encouraged
and supported
to breastfeed
An extended
postnatal stay
would be
beneficial to be
able to watch
for signs of
NAS, to be able
to support
breastfeeding,
and to be able
to provide
parenting
support.

Over half the
infants given
appointments
for the
outpatient
clinic
defaulted on
two or more
occasions.
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pregnancies
of drugmisusing
women
prescribed
substitute
methadone in
pregnancy
Ebner, N.,
Rohrmeister, K.,
Winklbaur, B.,
Baewert, A.,
Jagsch, R.,
Peternell, A., &
... Fischer, G.
(2007).
Management of
neonatal
abstinence
syndrome in
neonates born to
opioid
maintained
women. Drug &
Alcohol
Dependence,
87(2/3), 131138.

Purpose
Statement: To
examine the
effects of opioid
maintenance
treatment on the
incidence and
timing of NAS
compared to two
different NAS
treatment
(Phenobarbital v.
morphine).

Setting:
addiction
clinic,
medical
university of
Vienna

Design: Not
stated

Filippeli, A.,
White, L.,
Spellman, L.,
Broderick, M.,
Highfield, E.,
Sommers, E., &
Gardiner, P.
(2012). Non-

Purpose
Statement:
To examine the
potential of noninsertive
acupuncture as
an adjunctive
treatment for

Setting: BMC
Pediatric
Ward

Design:
retrospective
chart review

Sampling
Method:
convenience

Level of
Evidence:
level III

Level of
Evidence:
level VI

Sampling
Method: not
stated

Sample Size:
53 neonates
born to
Research
mothers with
Question: What
drug
is the best
addiction. 22
medication
received
regimen to treat
methadone,
pregnant mothers 17 received
with drug
slow-release
addiction?
morphine,
and 14
received
buprenorphin
e

All of the
neonates born
to mother
treated with the
opioid
maintenance
program
showed
APGAR scores
comparable to
babes of nonopioid
dependent
mothers. No
differences
were found
with weight,
length of head
circumference
between the
three groups.
Morphine is the
best drug for
neonates
suffering
from NAS.

Nursing
implications:
treat mother
with drug
addiction with
morphine
during
pregnancy to
improve
outcomes of
neonates.

Neonates
receiving NIA
treatments
revealed a
deeper sleep,
had better
feedings, and
demonstrated

The chart
review shows
potential for use
of NIA as an
adjunctive
treatment in
newborns with
NAS.

Study did not
exclude
women using
nicotine
and/or
cannabis, the
portion of
babies into
the NAS
groups was
not
randomized
but
dependent on
when they
were entered
into the
study, the
two
medications
have
different
durations of
actions, the
Finnegan
score was not
rated under
double-blind
conditions
Acupuncturis
ts were only
available one
day a week
resulting in
some babies
being treated
early in their

NEONATAL ABSTINENCE SYNDROME
insertive
acupuncture and
neonatal
abstinence
syndrome: A
case series from
an inner-city
safety net
hospital. Global
Advances in
Health and
Medicine. 1(4),
48-52.

newborns with
NAS.

Grossman, M.,
Berkwitt, A.,
Osborn, R., Xu,
Y., Esserman,
D., Shapiro, E.,
& Bizzaro, M.
(2017). An
initiative to
improve the
quality of care of
infants with
neonatal
abstinence
syndrome.
Pediatrics,
139(6).
doi:10.1542/peds
.2016-3360

Purpose
Statement:
To reduce the
ALOS for
infants with
NAS by
implementing
nonpharmacolog
ical
interventions.

Sample Size:
54 newborns
with NAS

34
more even
breathing.

stay and
others later
in their stay.

Research
Question:
Does NIA
provide
treatment of
symptoms
associated with
NAS?

Research
Question:
Will
implementing
nonpharmacolog
ical
interventions,
administration of
morphine as
needed, and
transfer of
infants directly
to the inpatient
unit reduce the
ALOS for

Setting: Yale
New Haven
Children’s
Hospital
Sampling
Method:
convenience
Sample Size:
287 infants
with NAS

Design:
retrospective
cohort study
Level of
Evidence:
level III

ALOS
decreased from
22.4 to 5.9
days.
Proportions of
methadoneexposed infants
treated with
morphine
decreased from
98% to 14%;
costs decreased
from $44 824
to
$10 289. No
infants were
readmitted for
treatment of
NAS and no
adverse
events were
reported.

Admit infants
directly to
inpatient unit,
administer as
needed
morphine, and
implement
nonpharmacolo
gical
interventions
such as placing
in low
stimulation
environment,
and rooming-in.

During
implementati
on of the
interventions
there were
changes in
hospital
policies that
may have
affected
results.

NEONATAL ABSTINENCE SYNDROME

Holmes, A.,
Atwood, E.,
Whalen, B.,
Beliveau, J.,
Jarvis, D.,
Matulis, J., &
Ralston, S.
(2016).
Rooming-in to
treat neonatal
abstinence
syndrome:
Improved
family-centered
care at lower
cost. Pediatrics.
137(6).

infants with
NAS?
Purpose
Statement:
To implement a
program for
NAS including
standardized
protocols for
scoring,
medications and
weaning, and a
calm rooming-in
environment, to
improve familycentered care
and to decrease
both length of
stay (LOS) and
hospital costs.

Research
Question:
Will
implementing a
coordinated
program
decrease the
LOS and
hospital costs of
infants with
NAS?
Isemann, B.,
Purpose
Meinzen-Derr,
Statement: To
J., & Akinbi, H. identify maternal
(2011). Maternal and neonatal
and neonatal
factors that are
factors impacting independent
response to
predictors of
methadone
response to
therapy in
methadone
infants treated
pharmacotherapy
for neonatal
for NAS.
abstinence
syndrome.
Research
Journal Of
Question: What

Setting:
Children’s
Hospital at
DartmouthHitchcock
Sampling
Method:
convenience

Design:
retrospective
cohort study
Level of
Evidence:
level III

35

Coordinated,
standardized
NAS program
safely reduced
pharmacologic
therapy, LOS,
and hospital
costs.

Implementing a
QI project
including
standardized
scoring,
rooming-in, and
environmental
management of
NAS can reduce
the use of
pharmacologic
therapy,
decrease LOS,
and reduce
hospital costs.

Most
mothers
maintained
on
buprenorphin
e as opposed
to methadone
which can
affect the
length of
treatment
needed.

Inverse
relationship
between the
amount of
mother’s breast
milk ingested
and length of
stay.

Research
Implications:
future studies
should be
conducted to be
able to identify
infants at risk
for rebound
NAS, care plan
for opiatedependent
women
beginning early
in pregnancy

Incomplete
data
collection
from the
medical
records.

Sample Size:
163 newborns
with NAS

Setting: The
University
Hospital in
Cincinnati,
Ohio
Sampling
Method: the
charts of all
newborns that
received
methadone
therapy for
NAS in the

Design:
retrospective
review
Level of
Evidence:
level III

Shorter median
duration of
methadone
therapy in
breastfed

Finnegan
abstinence
scoring
method is
designed for
term infants,
may not be

NEONATAL ABSTINENCE SYNDROME
Perinatology,
31(1), 25-29.
doi:10.1038/jp.2
010.66

impact do
maternal and
neonatal factors
impact response
to methadone
therapy for
neonatal
abstinence
syndrome?

NICU at The
University
Hospital
between
January 2002
and
December
2007 were
reviewed
Sample Size:
128 infants
Setting: 8
international
sites

Jones, H.,
Kaltenbach, K.,
Heil, S., Stine,
S., Coyle, M.,
Arria, A., & ...
Fischer, G.
(2010). Neonatal
abstinence
syndrome after
methadone or
buprenorphine
exposure. New
England Journal
Of
Medicine,363(24
), 2320-2331.
doi:10.1056/NEJ
Moa1005359

Purpose
Statement: To
figure out which
drug is the best
treatment for
neonates born to
mothers with
drug addiction.
Research
Question: Is
Methadone or
Buprenorphine a
better treatment
for neonates
born to mothers
with drug
addiction?

Sample Size:
175 pregnant
women with
opioid
dependence.

Kakko, J.,
Heilig, M., &
Sarman, I.
(2008).
Buprenorphine
and methadone
treatment of
opiate
dependence
during
pregnancy:
comparison of
fetal growth and

Purpose
statement: To
compare the
effects of fetal
buprenorphine
and methadone
exposure during
maintenance
treatment of
pregnant heroin
dependent
subjects?

Setting:
Stockholm
county,
Sweden

Sampling
Method:
randomized,
controlled

preterm and
term infants.

Sample Size:
47
pregnancies
in 39 women

should include
the risks of fetal
drug exposure,
the benefits of
breastfeeding,
and cautions
against rapidly
weaning infants
from breast
milk.

accurate in
detecting the
manifestation
of NAS in
preterm
infants.

Infants born to
mothers treated
with
buprenorphine
required
substantially
less morphine,
required
shorter
hospital; stays,
and had a
significantly
shorter
duration of
treatment for
NAS as
opposed to
mothers treated
with
methadone.

The preferred
method of
treatment for
mothers with
drug addiction
is
buprenorphine
to decrease
hospital stays,
decreased
morphine
administration,
and shorten the
treatment of
NAS care.

There were
different
rates of
treatment,
the amount
of morphine
given was
important but
not stated.

Pregnancies
exposed to
buprenorphine,
as opposed to
methadone,
resulted in less
infants going
through
withdrawal
syndrome and
NAS, higher
birth weights
related to full

Start addicted
women on
buprenorphine,
as opposed to
Methadone,
before they
become
pregnant to
reduce the
severity of NAS
and withdrawal
syndrome,
decrease the

Not
randomized,
only 39
women were
sampled,
different
addiction
severities and
ages,
assessments
of NAS were
not blind,
and

Reduced
incidence and
severity of
NAS in
breastfed
infants.

Design:
double-blind,
doubledummy,
flexibledosing study,
comparing
methadone
and
buprenorphin
e during
opioiddependent
pregnancies.
Level of
Evidence:
level V

Sampling
Method: nonrandomized

36

design:
comparison
of
prospectively
followed
buprenorphin
e-exposed
pregnancies
to the former
methadoneexposed
pregnancies

NEONATAL ABSTINENCE SYNDROME
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neonatal
outcomes in two
consecutive case
series. Drug &
Alcohol
Dependence,
96(1/2), 69-78.

Research
Question: is
Methadone or
Buprenorphine
better for
neonates born to
addicted mothers
in preventing
withdrawal
syndrome?

with opiate
dependence
and
buprenorphin
e
maintenance
treatment
(2001-2006),
and all 35
methadone
exposed
pregnancies
(26 women)
1982-2006

Level of
evidence:
level VI

term
pregnancies,
and shorter
length of stay
in the hospital.
Using
buprenorphine
before
conception
further
improved the
health of the
neonates.

length of stay in
the hospital, and
increase birth
weights by
improving
length of
pregnancies.

monitoring
of illicit drug
use was
incomplete.

Kuschel, C.,
Austerberry, L.,
Cornwell, M.,
Couch, R., &
Rowley, R.
(2004). Can
methadone
concentrations
predict the
severity of
withdrawal in
infants at risk of
neonatal
abstinence
syndrome?.
Archives Of
Disease In
Childhood -Fetal &
Neonatal
Edition, 89(5),
F390-3

Purpose
Statement: To
determine the
usefulness of
methadone
concentrations at
2 days of age in
predicting the
severity of NAS.

Setting:
National
Women’s
Hospital
Assessment
of Drugs and
Alcohol in
Pregnancy

Design: Not
stated

Maternal
methadone
dose does not
predict the
need for
treatment of
NAS.
However,
infants who
required
treatment for
NAS had lower
amounts of
methadone in
their system
than those who
did not receive
treatment.

Methadone
concentrations
may identify
infants at
greater risk of
developing
NAS, but may
not be accurate.

Small sample
size, not
randomized

McQueen K.A.,
MurphyOikonen J.,
Gerlach K.,
Montelpare W.
(2011). The
Impact of
Feeding Method

Purpose
Statement: To
determine
whether neonatal
abstinence scores
of infants
exposed to
methadone in

Predominantly
breastfed
infants had
fewer NAS
scores taken,
lower severity
scores, and
lower area

Practice
Implications:
mothers on
methadone
maintenance
programs
should be
encouraged and

Group
allocation
was selfselected
according to
the type of
infant
feeding,

Research
Question: Can
methadone
concentrations
predict the
severity of
withdrawal in
infants at risk of
neonatal
abstinence
syndrome?

Level of
Evidence:
level VI

Sampling
Method: not
stated
Sample Size:
25 infants

Setting:
Northwestern
Ontario

Design:
retrospective
chart review

Sampling
Method: All
methadoneexposed

Level of
Evidence:
level III

NEONATAL ABSTINENCE SYNDROME
on Neonatal
Abstinence
Scores of
MethadoneExposed Infants.
Advances in
Neonatal Care,
11(4), 282-290

utero differed by
infant feeding
method.
Research
Question: Does
feeding method
effect the NAS
scores of infants
exposed to
methadone in
utero?

infants born
between
March 2007
and March
2008 at the
selected
hospital and
who were
scored for
NAS before
discharge met
the criteria to
have their
charts
reviewed.
Sample Size:
28 motherinfant pairs

38
scores than
infants who
were not
predominantly
breastfed.
Breastfeeding
may have
helped to
decrease the
duration and
intensity of
NAS.

supported to
breastfeed in
the absence of
contraindication
s, mothers
should be
educated during
pregnancy on
the benefits of
breastfeeding,
healthcare
professionals
should be aware
of current
breastfeeding
recommendatio
ns for women
on methadone.
Research
Implications:
additional
research should
be conducted on
breastfeeding
among
methadonemaintained
women to
explore issues
such as reasons
for low
breastfeeding
rates, healthcare
providers’ ideas
and attitudes
about
breastfeeding
on methadone,
the effects of
methadone on
NAS, and
effective
interventions to
support
methadone-

limiting the
ability to
control for
potentially
confounding
variables
other
confounding
variables
(SES,
maternal
education,
etc.) were not
evaluated
because they
were not
included in
the charts
small group
sizes
instrument
bias may
exist
(Modified
Finnegan
Scoring
Tool)
self-report
was used to
assess
eligibility
criteria for
methadone
use
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39
maintained
mothers to
breastfeed.

Mohamed E.,
Abde-Latif,
Pinner J., Clews
S., Cooke F., Lui
K., Oei J. (2006).
Effects of Breast
Milk on the
Severity and
Outcome of
Neonatal
Abstinence
Syndrome
Among Infants
of DrugDependent
Mothers.
Pediatrics, 117
(6)

Purpose
Statement: To
assess the effects
of breast milk on
the severity and
outcome of
neonatal
abstinence
syndrome.
Research
Question: Does
breast milk
reduce the
severity and
improve the
outcome of
neonatal
abstinence
syndrome?

Setting:
Department
of Newborn
Care, Royal
Hospital for
Women,
Randwick,
New South
Wales,
Australia
Sampling
Method: the
charts of all
drugdependent
mothers who
were admitted
to the
Department
of Newborn
Care between
1998 and
2004 were
reviewed
Sample Size:
190 drugdependent
mother-infant
pairs

Design:
retrospective
chart review
(cohort
study)
Level of
Evidence:
level III

Predominantly
breastfed
infants had
significantly
reduced mean
NAS scores,
delayed onset
of withdrawal,
a decreased
need for
pharmacologic
interventions,
and shorter
hospitalization
than formulafed infants.
No difference
was found
between infants
fed breast milk
by bottle or
gavage tubes
and infants
who were
exclusively
breastfed.
Breastfed
infants exposed
to multiple
drugs had
worse scores
than infants
exposed to
single in utero
drugs, but had
considerably
lower mean
Finnegan
scores during
the entire 9

Practice
Implications:
Women should
be encouraged
to breastfeed

Finnegan
scoring
system was
used (only
validated for
opiate
withdrawal),
some
neonates may
have been
exposed to
other
substances
institution
relies on
voluntary
maternal
disclosure as
indicator of
drug use,
study could
have been
influenced by
unidentified
drugs
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40
days than
formula-fed
infants.

Newman, A.,
Davies, G., Dow,
K., Holmes, B.,
Macdonald, J.,
Mcknight, S., &
Newton, L.
(2015).
Rooming-in care
for infants of
opioid dependent
mothers.
Canadian
Family
Physician.
61(12), 555-561.

O'Connor, A. B.,
Collett, A., Alto,
W. A., &
O'Brien, L. M.
(2013).
Breastfeeding
Rates and the
Relationship
Between
Breastfeeding
and Neonatal
Abstinence

Purpose
Statement:
To implement a
rooming-in
program to
support close
uninterrupted
contact between
opioiddependent
women and their
infants in order
to decrease the
severity of NAS
scores, lessen the
need for
pharmacotherapy
, and shorten
hospital stays.
Research
Question:
Does rooming-in
decrease the
severity of NAS
scores, lessen the
need for
pharmacotherapy
, and shorten
hospital stays?
Purpose
Statement: To
determine
whether
breastfeeding is
related to the
duration,
severity, and
frequency of
pharmacologic
treatment for
neonatal

Setting:
Ontario
Sampling
Method:
convenience
Sample Size:
45 women
taking
chronic
opioid
therapy

Setting:
Maine
General
Medical
Center,
United States
Sampling
Method:
office and
hospital
charts of all

Design:
retrospective
cohort study
Level of
Evidence:
level III

Design:
retrospective
chart review
Level of
Evidence:
level III

With the
rooming-in
program, the
proportion of
infants
requiring
pharmacothera
py decreased
from 83.3% to
14.3% and the
average length
of stay
decreased from
25 days to 8.

Infants who are
breastfed
experience less
severe NAS
than infants
who are not
breastfed.
Infants who are
breastfed are
less likely to
require

Rooming-in
might decrease
the need for
pharmacotherap
y and decrease
the length of
stay for infants
with NAS.

Clinical
Implications:
breastfeeding
education
should be
provided during
the prenatal
period
Research
implications:

Possible bias
because the
NAS scoring
tool that was
used to
quantify
severity
relies on
some
subjective
judgement.

Since this
study was a
retrospective
chart review,
the results
can only be
used to
generate
potential
hypotheses
(cannot
establish

NEONATAL ABSTINENCE SYNDROME
Syndrome in
Women
Maintained on
Buprenorphine
During
Pregnancy.
Journal Of
Midwifery &
Women's Health,
58(4), 383-388.
doi:10.1111/jmw
h.12009

abstinence
syndrome
(NAS).
Research
Question: Does
breastfeeding
have an effect on
the duration and
severity of NAS
and the
frequency of
pharmacologic
treatment for
neonatal
abstinence
syndrome?

opioiddependent
pregnant
women
maintained on
buprenorphin
e and treated
in an
integrated
maternalinfant opioid
dependence
treatment
program from
December
2007 to
August 2012
were
reviewed

41
pharmacologic
treatment than
infants who are
not breastfed.
Symptoms of
NAS started to
resolve about 2
hours earlier in
the
breastfeeding
cohort.

further research
to identify the
effects of
breastfeeding
on NAS is
necessary

cause and
effect).

Practice
Implications:
Breastfeeding,
which has been
associated with
a decreased
need for NAS
treatment and
promotes infant
attachment and
bonding, should
be encouraged.

Maternal
drug use was
mostly selfreported
(pregnant
women often
minimize
report of
drug use)

Not possible
to distinguish
the potential
impact of
breastfeeding
from other
nonpharmaco
logic NAS
interventions,
swaddling
and skin-toskin contact
may occur
with
breastfeeding
.

Sample Size:
85 maternalinfant pairs
Pritham, U. A.,
Paul, J. A., &
Hayes, M. J.
(2012). Opioid
Dependency in
Pregnancy and
Length of Stay
for Neonatal
Abstinence
Syndrome.
JOGNN: Journal
Of Obstetric,
Gynecologic &
Neonatal
Nursing, 41(2),
180-190.
doi:10.1111/j.15
526909.2011.0133
0.x

Purpose
Statement: To
examine opioid
replacement
therapy in
pregnancy and
effect on
neonatal
outcomes,
including length
of hospital stay
for neonatal
abstinence
syndrome.
Research
Question: What
effects do opioid
replacement
therapy in
pregnancy and
breastfeeding

Setting: labor
and delivery
unit and
neonatal
intensive care
unit, Eastern
Maine
Medical
Center,
Bangor,
Maine
Sampling
Method: the
EMRs of all
opioiddependent
pregnant
women and
their
newborns
delivered

Design:
retrospective
descriptive
study
Level of
Evidence:
level III

Breastfeeding
may be
protective for
neonates
withdrawing
from opioids
length of stay
was shorter in
breastfed
neonates than
formula-fed
neonates or
neonates who
received
formula and
breast milk.
Breastfeeding
was associated
with a
decreased rate

Research
Implications:
Future research
is needed to
determine the
differences in
NAS between
neonates whose
initial exposure

confounding
variables
were not
evaluated
researcher
was
dependent on
the
availability
of medical
records
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after birth have
on neonatal
outcomes?

Raith, W.,
Schmolzer, G.,
Resch, B.,
Reiterer, F.,
Avian, A.,
Koestenberger,
M., &
Urlesberger, B.
(2015). Laser
acupuncture for
neonatal
abstinence
syndrome: A
randomized
controlled trial.
Pediatrics,
136(5), 876-884.
doi:10.1542/peds
.2015-0676

Purpose
Statement:
To reduce
duration of
morphine
therapy and
hospital stay by
implementing
adjuvant laser
acupuncture.
Research
Question: Does
adjuvant
laser
acupuncture
reduce
duration of
morphine
therapy and
length of
hospital stay?

between
January 1,
2005 and
December 31,
2007 were
reviewed
Sample Size:
152 opioiddependent
pregnant
women on
methadone
maintenance
therapy (n=
136) or
buprenorphin
e
maintenance
therapy
(n=16) during
pregnancy
and their
neonates
Setting:
Division of
Neonatology,
University
Hospital of
Graz
Sampling
Method:
convenience
Sample Size:
28 newborns
with NAS

Design:
prospective,
randomized,
controlled,
blinded,
single-center
study
Level of
Evidence:
level II

42
of infant
treatment for
withdrawal
from prenatal
methadone or
buprenorphine
exposure.

to opioid
replacement
therapy
occurred at
different
gestational ages
and with
different
durations of
exposure.

Adjunctive
laser
acupuncture
significantly
reduced the
duration of
morphine
therapy in
newborns with
NAS.

Laser
acupuncture can
be used as
adjuvant
therapy along
with morphine
in order to
reduce the
duration of
morphine
therapy in
infants with
NAS.

Small sample
size because
Austria has a
low
incidence of
NAS
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Welle-Strand,
G.K., Skurtveit,
S., Jansson,
L.M., Bakstad,
B., Bjarko, L., &
Ravndal, E.
(2013).
Breastfeeding
reduces the need
for withdrawal
treatment in
opioid-exposed
infants. Acta
Paediatrica,
102(11), 10601066.
doi:10.1111/apa.
12378

Purpose
Statement: To
examine the rate
and duration of
breastfeeding in
a cohort of
women in opioid
maintenance
treatment (OMT)
in Norway, as
well as the effect
of breastfeeding
on the incidence
and duration of
NAS.
Research
Question: How
do the outcomes
differ for
methadone and
buprenorphineexposed infants
who are
breastfed
compared to
methadone and
buprenorphineexposed infants
who are not
breastfed?

Setting:
Norway
Sampling
Method: The
participants
were
recruited
through
regional
treatment
centers for
OMT and
through
users’
organizations
for patients in
OMT.
Sample Size:
124 women
treated with
either
methadone or
buprenorphin
e during
pregnancy
and their
newborns.

Design: two
retrospective
studies, one
prospective
study
Level of
Evidence:
level III,
level II
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Reduced need
for
pharmacologic
al NAS
treatment in
breastfed
compared to
formula-fed
methadoneexposed
infants.
Shorter length
of
pharmacologic
al NAS
treatment in
breastfed
infants
compared to all
exposed infants
and
methadoneexposed infants
did not find
decreased
incidence or
duration of
pharmacologic
al NAS
treatment
among
buprenorphineexposed
infants.

Practice
Implications:
support to
initiate and
continue
breastfeeding
should begin
early in
pregnancy for
OMT women,
advice about
breastfeeding
from
professionals
should be
consistent

Only one
part of the
study had a
prospective
design

Research
Implications:
there is a need
for more
research,
especially on
the effects of
breastfeeding
on NAS for
buprenorphineexposed
neonates

children in
study were
born at 18
different
hospitals

retrospectivel
y designed
study period
may be less
accurate than
the
prospective
design due to
reliance on
subject recall

questionnaire
did not cover
the extent of
breastfeeding
study groups
were small
(especially
for
buprenorphin
e-exposed
neonates)

